Company: PTHS
Filing Date: 2025-11-14
Form Type: PRE 14A
Source: 0001753926-25-001803
Chunk: 23

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-14
Form: PRE 14A
Chunk 23
---
nuettel resigned as Chief Executive Officer on July 1, 2025 with the consummation of the Merger between Channel and LNHC and 
 was appointed to the position of Chief Financial Officer of Pelthos on July 1, 2025.                                          |

| (3) | Mr.                                                                                                                             
 Rangarao was appointed to the position of Chief Commercial Officer of Pelthos on July 2, 2025 following the consummation of the 
 Merger between Channel and LNHC.                                                                                                |

| (4) | Represents                                                                                                                
 the portion of Dr. Lang’s salary attributable to his services to the Company during the year ended December 31, 2023. Dr. 
 Lang was appointed Chief Medical Officer of the Company, effective May 15, 2023. Dr. Lang’s employment was terminated on  
 July 1, 2025.                                                                                                             |

| (5) | Mr.                                                                                                                               
 Kopfli stepped down as Chief Financial Officer with the hiring of Mr. Knuettel, effective June 10, 2022. In addition, in July     
 2023, Mr. Knuettel assumed the role of Interim Chief Executive Officer and stepped down as Chief Strategy Officer, and Mr. Kopfli 
 was appointed Vice Chairman and Chief Strategy Officer. On December 1, 2023, the Company terminated Mr. Kopfli as Vice Chairman   
 and Chief Strategy Officer.                                                                                                       |

| (6) | Represents                                                                                                               
 the portion of Mr. Kopfli’s salary attributable to his services to the Company during the years ended December 31, 2023. |

<div align='center'>15</div>

Pre-Merger Employment Agreements and Arrangements

Christian Kopfli

We were a party to an amended and restated employment agreement with Christian Kopfli, dated July 28, 2023. Pursuant to such agreement, Mr. Kopfli agreed to serve as our Vice Chairman and Chief Strategy Officer, in consideration for an annualized salary of $275,000, payable in cash at the rate of $5,000 per month (a minimum of $1,125 per week), with the remainder accrued and paid as of the earliest of a sale or liquidation of the Company, the Company’s bankruptcy or three days after the approval by the Board of a funded budget with appropriately established milestones subsequent to the effective date of a Form S-1 registration statement (“Post-registration Approval”). Mr